32014-03-2 Usage
Uses
Used in the Chemical Industry:
1-(2-hydroxy-ethanesulfonyl)-propan-2-ol is used as a solvent and stabilizer for various industrial applications due to its high solubility and low toxicity. Its ability to dissolve a wide range of substances and provide stability to formulations makes it a valuable component in the chemical industry.
Used in the Production of Dyes and Pigments:
HEPS is used as a key component in the production of dyes and pigments, where its solubility and stability properties are crucial for creating vibrant and long-lasting colors.
Used in the Pharmaceutical Industry:
1-(2-hydroxy-ethanesulfonyl)-propan-2-ol is utilized in the pharmaceutical industry for its versatility and low toxicity, making it suitable for use in the development and manufacturing of various medications.
Used as a Viscosity Modifier:
In various manufacturing processes, HEPS is used as a viscosity modifier to control the flow and consistency of different compositions, enhancing the overall quality and performance of the final products.
Check Digit Verification of cas no
The CAS Registry Mumber 32014-03-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,0,1 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 32014-03:
(7*3)+(6*2)+(5*0)+(4*1)+(3*4)+(2*0)+(1*3)=52
52 % 10 = 2
So 32014-03-2 is a valid CAS Registry Number.
32014-03-2Relevant articles and documents
N-AMINO TETRAHYDROTHIAZINE DERIVATIVES, METHOD OF MANUFACTURE AND USE
-
Page/Page column 19, (2008/12/07)
This invention comprises the innovative synthesis of N-amino tetrahydrothiazine free bases and their salts. This invention further comprises the use of the derivatives and their therapeutic application as anticancer agents. Further this invention comprises their manufacture and use.
NITROFURAN COMPOUNDS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS
-
Page/Page column 49, (2008/06/13)
The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.